 | Up a level |
Liu, Drolaiz H W; Grabsch, Heike I; Gloor, Beat; Langer, Rupert; Dislich, Bastian (2023). Programmed death-ligand 1 (PD-L1) expression in primary gastric adenocarcinoma and matched metastases. Journal of cancer research and clinical oncology, 149(14), pp. 13345-13352. Springer 10.1007/s00432-023-05142-x
Saldanha, Oliver Lester; Muti, Hannah Sophie; Grabsch, Heike I; Langer, Rupert; Dislich, Bastian; Kohlruss, Meike; Keller, Gisela; van Treeck, Marko; Hewitt, Katherine Jane; Kolbinger, Fiona R; Veldhuizen, Gregory Patrick; Boor, Peter; Foersch, Sebastian; Truhn, Daniel; Kather, Jakob Nikolas (2023). Direct prediction of genetic aberrations from pathology images in gastric cancer with swarm learning. Gastric cancer, 26(2), pp. 264-274. Springer 10.1007/s10120-022-01347-0
Lang-Schwarz, Corinna; Angeloni, Miriam; Agaimy, Abbas; Atreya, Raja; Becker, Christoph; Dregelies, Theresa; Danese, Silvio; Fléjou, Jean-François; Gaßler, Nikolaus; Grabsch, Heike I; Hartmann, Arndt; Kamarádová, Kateřina; Kühl, Anja A; Lauwers, Gregory Y; Lugli, Alessandro; Nagtegaal, Iris; Neurath, Markus F; Oberhuber, Georg; Peyrin-Biroulet, Laurent; Rath, Timo; ... (2021). Validation of the ‘Inflammatory Bowel Disease—Distribution, Chronicity, Activity [IBD-DCA] Score’ for Ulcerative Colitis and Crohn´s Disease. Journal of Crohn's & colitis, 15(10), pp. 1621-1630. Oxford University Press 10.1093/ecco-jcc/jjab055
Alderson, Derek; Cunningham, David; Nankivell, Matthew; Blazeby, Jane M; Griffin, S Michael; Crellin, Adrian; Grabsch, Heike I; Langer, Rupert; Pritchard, Susan; Okines, Alicia; Krysztopik, Richard; Coxon, Fareeda; Thompson, Joyce; Falk, Stephen; Robb, Clare; Stenning, Sally; Langley, Ruth E (2017). Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial. The lancet oncology, 18(9), pp. 1249-1260. Elsevier 10.1016/S1470-2045(17)30447-3
